Chronic lymphocytic leukemia of B-cell origin (B-CLL) is generally thought t o arise by neoplastic transformation of B lymphocytes, which express CD5 and have features of an early stage of B-cell differentiation. To study isotypeswitched B-CLL as a potentially more differentiated variant, we performed genetic and functional immunoglobulin (le) gene analysis in two cases of CD5+ B-CLL in which the peripheral blood mononuclear cells (PBMC) secreted predominantly IgA (CLL-249) or IgG (CLL-412) when stimulated with pokeweed mitogen in vitro. By cDNA sequencing and by studies of CLL-heterohybridomas, CLL-249 expresses the heavy chain constant region Ca as anticipated, while CLL-412 expresses Cp, not Cy. In CLL-249, the expressed VH gene is 98% homologous t o VH26, a germline vH3 gene that occurs frequently in the fetal repertoire, and which has been associated with anti-DNA specificity. The VL gene of CLL-249 is a A HE CLONAL CELL in chronic lymphocytic leukemia
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T of B-cell origin (B-CLL) expresses the pan-B cell
antigens Ia, CD19, and CD201s2 and has clonal rearrangements of the immunoglobulin (Ig) heavy chain locus. Most B-CLL cells express low quantities of surface Ig, 10-fold less than normal mature B cells, and the isotype of surface Ig, as detected by flow cytometry, is usually IgM or a combination of IgM and IgD.2 More than 90% of cases of B-CLL also express CD5, an antigen first described as the T1 antigen on T lymphocytes. There is evidence from studies of murine and human B cell^^-^ that CD5+ B cells occur normally and may belong to a B-cell lineage separate from the classic pathway of B-cell differentiation. Studies of Lyl+ (the murine counterpart of CD5) B-cell tumor models in certain strains of mice, and of CD5+ human malignancies, including B-CLL, have demonstrated numerous similarities between the normally occurring CD5+ B cell and CD5+ malignancies. At the phenotypic level, these similarities include low surface expression of IgM and expression of the mouse erythrocyte rosette r e c e p t~r .~,~ At a functional level, both the normal CD5+ B cel15,6,9 and many B-CLL cellslOJ1 appear to express Ig with autospecificities. At the genetic level, both normal Lyl+ B celW and Lyl+ tumors13 in mice use a restricted set of heavy and light chain V genes. On the basis of frequent expression of certain cross-reactive idiotypes,14J5 of biased VH gene expression by Northern analysis, 16 and of nucleotide sequence data,l7-*l human CLL demonstrates restricted V gene usage, and expresses V genes in unmutated form. Together, these observations suggest that B-CLL cells resemble the normally occurring CD5+ B-lymphocyte population, and may be derived from that subset by neoplastic transformation.
However, some examples of CLL variants have been reported that have characteristics different from the typical CD5+ B-CLL. For instance, a CD5-variant of B-CLL was reported to have significant intraclonal diversity of V gene nucleotide sequence, indicating that somatic mutation of the expressed VH gene can be active in some cases of CLL. 22 In a study of ultrastructural characteristics of CLL, there VL gene for which the germline sequence is not known. In CLL-412, the VH gene is 100% homologous t o the V"1 gene of a published anti-DNA antibody (21/28), and is probably a germline gene sequence; the VL gene is 100% homologous t o 15AVKI, also a germline gene. The supernatant antibody of the CLL-412 heterohybridoma is an IgM-K, which reacts with ssDNA and cardiolipin. The CLL-249 heterohybridoma secreted IgA-A, which bound none of the antigens tested, a finding that may be related t o amino acid differences from the probable germline V genes. The demonstration of an in vivo isotype-switched variant, such as CLL-249, suggests that B-CLL may be a heterogeneous group of clonal disorders, of which less common variants may have features of more differentiated B-cell stages, such as isotype switching.
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was heterogeneity in the degree to which the components (rough endoplasmic reticulum and Golgi apparatus) of the Ig secretory pathway have matured.23 Thus, B-CLL may be a heterogeneous group of clonal disorders, of which the most common variant expresses IgM and CD5, and may correspond to the normal CD5+ B lymphocyte. However, less common variants may have features characteristic of more differentiated B cells.
We have focused on heavy chain class-switched B-CLL as a variant subset that might represent a more mature stage of B-cell differentiation. Several reported series of CLL patients include a minority of cases in which surface IgG or IgA is observed by flow cytometry.lO,a However, the question has been raised whether the IgG or IgA found on the cell surface is truly expressed by the CLL cells in vivo. 
MATERIALS AND METHODS

Patient Material
Peripheral blood mononuclear cells (PBMC) from two patients (CLL-249 and CLL-412) with B-CLL were isolated by density gradient centrifugation and frozen in dimethylsulfisoxazole until use. The diagnosis of CLL was based on standard clinical criteria. 30 The clinical characteristics, karyotype analysis, and studies of T-cell regulation of B-cell function have been reported previously for CLL-249.3'-34 Flow cytometry was performed as described previo~sly.~~
Heterohybridomas
Cryopreserved PBMC were thawed and resuspended in medium consisting of RPMI (Gibco, Grand Island, NY) with 10% fetal calf serum (FCS; Hyclone, Logan, UT) and 1% glutamine (Flow Laboratories, McLean, VA), and were cultured overnight with 0.75 pg/mL pokeweed mitogen (Sigma, St Louis, MO), 10 ng/mL 12-0-tetradecanoylphorbol 13-acetate (TPA) (CalBiochem, La Jolla, CA), and 10% (vol/vol) B-cell growth factor (Cellular Products, Buffalo, NY). On the following day, fusions were performed according to the protocol of Lane et al?5 PBMC cells, 3.0 to 5.5 x lo6, were mixed with 2.0 to 3.3 x lo6 K6H6 cells:6 concentrated by centrifugation, and exposed to 50% polyethylene glycol (Kodak 1450, Rochester, NY), 5% dimethylsulfisoxazole in serum-free Kennett's H Y (JRH Biosciences, Lenexa, KS) medium for 45 to 75 seconds at 37"C, diluted slowly in serum-free HY medium, washed once, and resuspended in a 1:l mixture of fresh HY and HY conditioned by K6H6 cells. The entire fusion was plated at one drop per well on four 96-well plates, incubated overnight, and an additional drop of fresh HY with HAT (Sigma), for final concentrations of 1 x mol/L hypoxanthine, 4 x lo-' mol/L aminopterin, and 1.6 x mol/L thymidine, was added to each well. Wells were scored for growth after 3 to 4 weeks and supernatants screened by enzyme-linked immunosorbent assay (ELISA).
ELISA Assays
The ELISA-based method has been described p r e v i o~s l y .~~,~~ For isotype determination in heterohybridoma supernatants, 96-well plates (Dynatech Laboratories, Chantilly, VA) were coated overnight with goat anti-human Ig polyvalent for human IgM, IgG, and IgA (Sigma) or goat antihuman IgA (for CLL-249) (Capell, West Chester, PA) diluted to 5 pg/mL in phosphate-buffered saline (PBS). After blocking with 0.5% nonfat dry milk (Carnation, Los Angeles, CA) in PBS and three washes with PBS/O.l% Tween 20 (Bio-Rad, Richmond, CA) using an automated ELISA washer (Dynatech), dilutions of affinity purified human Ig standards, IgM (Tago, Burlingame, CA), IgG (Sigma), and IgA, K and A (Tago), or dilutions of heterohybridoma, supernatants were incubated. After three washes, 150 pL of Isotype determination. alkaline phosphatase conjugates of goat anti-human IgM, goat anti-human IgG, goat anti-human IgA, goat anti-human K and goat anti-human A (Sigma) were incubated at concentrations of 2 pg/mL. Freshly made P-nitrophenyl phosphate (Sigma) at 125 pg/mL was added to each well and the optical density at 410 nm, zeroed against a negative control well with medium only, was read on the MR700 ELISA reader (Dynatech).
As previously described:8 microtiter plates were incubated with protamine sulfate (Sigma), washed three times, and incubated overnight with 100 pL of DNA at 50 pg/mL, which had been denatured at 95°C for 5 minutes and chilled rapidly. Plates were washed three times, blocked with 1% bovine serum albumin (BSA)/PBS/0.02% NaN3, and incubated with antibody dilutions made in the blocking buffer. After three washes, the alkaline phosphatase conjugates described above were incubated, and the plates then washed and developed.
Anticardiolipin ELISA.39 Microtiter plates were coated overnight with 35 pL of a 1:lOO dilution of cardiolipin (Sigma) in ethanol, washed four times by hand with PBS/O.l g/L CaC12 (Gibco), and blocked with 120 pL of 10% FCS/PBS/O.l g/L CaC12. Plates were incubated with dilutions of antibodies, washed four times with PBS/O.l g/L CaC12, and the appropriate alkaline phosphatase conjugates described above were added. Plates were then washed and developed as above.
Rheumatoid factor activity." Microtiter plates were coated with affinity purified goat anti-human IgM or anti-human IgA (Capell) overnight, washed as above, blocked with 3% BSA/PBS/O.l% NaN3, washed, and incubated with test antibodies diluted in blocking buffer. Plates were washed and incubated with diluted normal rabbit serum. After washing, affinity-purified goat-anti rabbit IgG alkaline phosphatase conjugate (Sigma) diluted 1:1,000 was incubated, washed, and developed.
Anti-DNA ELISA.
Southem Hybridization
High-molecular weight DNA was extracted from PBMC from both CLLs, from the heterohybridoma cell lines, from the fusion partner K6H6, and from human granulocytes by standard methods using phenol/chloroform."l Five to 10 micrograms of each genomic DNA was digested with restriction enzymes Hind111 (New England Biolabs, Beverly, MA) orXbaI (BRL, Gaithersburg, MD) using the buffer supplied by the manufacturer, electrophoresed through 0.5% Seakem agarose gel (FMC, Rockland, ME) and transferred to a Duralon membrane (Stratagene, Ja Jolla, CA), and crosslinked with UV irradiation (Stratalink, Stratagene). Membranes were prehybridized in 7% sodium dodecyl sulfate (SDS)/40 mmol/L NaHP04/1 mmol/L EDTA, pH 7.4, at 42"C," and hybridized in a fresh aliquot of the same solution to a JH probe43 radiolabeled by random priming (Prime-it kit, Stratagene). Membranes were washed at high stringency at 65°C in 5% followed by 2% SDS/40 mmol/L NaHP04/1 mmol/L EDTA, pH 7.4, and exposed to XAR film (Kodak) for 2 to 14 days.
cDNA-Polymerase Chain Reaction
Total cellular RNA was extracted from PBMC from both patients using guanidium isothiocyanate (Boehringer Mannheim, GmbH, Germany) followed by isopropanol pre~ipitation.~~ Firststrand cDNA was synthesized from 1 to 3 pg of total RNA, using AMV reverse transcriptase (Life Sciences, St Petersburg, FL) and synthetic oligonucleotide primers specific for the constant regions of human Ig heavy and light chains as listed below. Second-strand and subsequent polymerase chain reaction (PCR) amplification was performed using 2.5 U recombinant Taq polymerase (Amplitaq, Perkin Elmer Cetus, Norwalk, CT), 0.2 pmol/L primers, and the buffer recommended by the manufacturer with 1.5 mmol/L For personal use only. on September 24, 2017. by guest www.bloodjournal.org From MgC12, in a programmable thermocycler (Coy Laboratory Products, Ann Arbor, MI) using 30 cycles of denaturing at 94°C for 1 minute, annealing at 55°C for 1 minute, and synthesis at 72°C for 1 minute. The last 72°C synthesis cycle was continued for a total of 10 minutes.
The 3' primer for PCR amplification was the same constantregion primer as that used for first-strand cDNA synthesis. The 5' primer was determined, in the case of the heavy chains, by trial of each of six oligonucleotide primers that are specific for the six heavy chain VH family leader exons. The leader primer, which gave an amplification product of the appropriate size on ethidium stained gel (not shown), was used for preparative amplifications. In the case of the K light chain, a similar trial of each of four oligonucleotide leader primers specific for human K subgroups 1 through 4 was used to determine the 5' primer. For the A light chain, a single framework 1 primer was used as the 5' primer.
Cloning and Sequencing
As previously de~cribed?~ the amplification products were purified through agarose gels, blunt end-ligated into a Sma 1 cut, phosphatase-treated PBS vector (Stratagene), and electroporated into the XL1-Blue strain of Esherichiu coli (Stratagene). Bacteria were selected for growth in the presence of ampicillin and by blue/white selection. Colonies found to contain an appropriatesized insert by restriction analysis of alkaline lysis preparations of plasmid DNA were sequenced by the dideoxynucleotide termination method in both directions using the Sequenase I1 kit (United States Biochemical, Cleveland, OH) and the universal primers "-40" and "reverse." Sequence analysis was performed using the DNA Inspector I1 (Textco, West Lebanon, NH), the Wisconson Analysis Package,& and the FASTA program4' for searching the Genbank/EMBL database.
I@ Purification
The supernatant of 412-2A11 was assayed for anti-DNA specificity without purification. Because the supernatant of 249-1611 appeared by initial ELISA to contain only nanogram per milliliter quantities of IgA, the supernatant was purified and concentrated over a 2-mL goat anti-human IgM, IgG, IgA-Sepharose affinity column (Sigma).48 The column was equilibrated with PBS and the supernatant applied by slow gravity flow. Bound antibody was eluted with 0.1 mol/L glycine HCl, pH 2.4, and immediately neutralized to pH 7.0. Fractions with nonzero absorbancy at 280 nm were pooled, concentrated, and dialyzed against PBS by vacuum concentration through collodion bags of pore size 75,000 molecular weight (Schleicher and Schuell, Keene, NH). The affinity-purified material was demonstrated to be free of albumin and to contain heavy and light chains of the appropriate molecular weights by polyacrylamide gel electrophoresis with and without reduction with dithiothreitol (not shown). The affinity-purified material was demonstrated by ELISA to contain only human IgA-A.
Oligonucleotides
Oligonucleotides were synthesized by automated phosphotriester chemistry (Applied Bioscience, Foster City, CA), diluted to stock concentrations and used without further purification. The sequences are listed below (primer: sequence 5' + 3'). 
RESULTS
In Ktro Stimulation Assay
PBMC from two patients, 249 and 412, with CLL were studied. Flow cytometric analysis of surface markers on unstimulated PBMC showed 92% and 68% CD5+ B cells for CLL-249 and CLL-412, respectively. Staining for K, X, IgM, IgD, IgG, and IgA (not shown) was not above background fluorescence. The typical flow cytometry findings in B-CLL show low levels of either surface IgM or IgM and IgD expression; Ig is undetectable in as many as 6% to 15% of CLLs,24,49 depending on the sensitivity of the technique used. As shown in Table 1 , mitogens stimulated Ig secretion in both cases. The stimulation studies for CLL-249 have been reported previously, and showed that PBMC from CLL-249 secreted predominantly IgA when incubated in vitro with pokeweed mitogen and autologous T cells.34 PBMC from CLL-412 secreted predominantly IgG with mitogenic stimulation. Since the most common re- 3) , and that hctcrohybridoma 412-2A11 (lanc 6) contains both rcarrangcd hcavy chain allclcs of CLL-412 (lanc 5). 412-3F8 (lanc 7), on thc othcr hand, contains hcavy chain allclcs that appear to bc unrclatcd to those of CLL-412. Thc Xbal digcst (not shown) also dcmonstratcd that hctcrohybridomas 249-IC1 1 and 412-2A11 sharc rcarrangcd hcavy chain allclcs with thcir corrcsponding CLL PBMC, whilc 412-3F8 docs not. Thcsc findings suggcst that thc human Ig in thc supcrnatants of hctcrohybridomas 249-IC1 1 and 412-2A11 arc cncodcd by the cxprcsscd Ig gcncs of thc CLL cclls.
Nucleotide Sequences
The nuclcotidc scqucnccs of thc variablc regions of thc cxprcsscd hcavy and light chains from CLL-412 and CLL-249 wcrc dctcrmincd by a rcversc transcriptasc (RT)-PCR tcchniquc, in which total RNA from PBMC was uscd as the tcmplatc. As described in thc mcthods, thc 5' amplification primcr was dctcrmincd by trial of cach of six hcavy chain lcadcr primcrs, or cach of four K light chain lcadcr primcrs. visiblc on cthidium staincd gcl (not shown) with the VH3-C, primcr pair and the VA-CA primer pair; for CLL-412, amplified bands wcrc visiblc with the VHl-Cy primer pair and with thc VKI-CK primer pair. Thcsc amplification products wcrc cloncd into E coli and three to four bacterial isolatcs scqucnccd to form a consensus scqucncc. Figure 2 shows the hcavy chain sequence for CLL-249 comparcd with thc publishcd gcrmlinc scqucnce idcntificd as having thc highcst V gcnc nuclcotidc homology by FASTA4' scarchcs of thc Gcnbank/EMBL data-
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ca primer * * f f t t t * *. . *** f f f I * . base. The four colonies sequenced (Al, A2, A6, A7) were identical except for a single T to C difference in codon lOOG of colony A6. This discrepancy may be attributable to infidelity of Taq polymerase as discussed previou~ly.~~ The CLL-249 VH gene coding region is 98% homologous to the VH26 g e n e ? I~~~ a vH3 germline gene. The VH26 gene is used, in unmutated form, in 30P1, a rearranged heavy chain frequently expressed in a cDNA library made from fetal l i~e r ?~,~~ and also in the 18/2 family of anti-DNA antibodies from a patient with systemic lupus erythematosus (SLE).s5 In the VH gene of CLL-249, there are eight nucleotide differences from the germline VH26 sequence, of which six give rise to amino acid differences; three of eight of those nucleotide differences lie within CDR regions. Based on the degree of homology, the VH26 gene is probably the germline precursor of the VH gene in CLL-249, with the nucleotide differences representing somatic mutations of VH26; alternatively, CLL-249 could use another VH gene closely related to VH26 or an allelic variant of VH26.
The D region of CLL-249 is most homologous to the germline DN1 regions6 (see Fig 4) , and in codon 99, the difference from the DN1 sequence (CA to TG) is the same as that described by Yamada et als7 as possible evidence for the existence of another germline segment in the DN group.
There are six untemplated nucleotides 5' of the D segment in CLL-249, and nine on the 3' end; these are presumed to be N sequences introduced at the time of VD and DJ joining. The 54 joining segment is used with no deviation from the published germline sequence.58 The 5' end of the constant region sequence, between the J region and the amplification primer, is identical to that of Coll (and Ca2).S9
The A light chain sequence of CLL-249 (not shown, submitted to the Genbank/EMBL database under accession number L01277) was 97.5% homologous to cML~O,~O a rearranged A light chain sequence derived from a cDNA library made from normal peripheral blood and more than 90% hoinologous to two other published cDNA sequences.60,61 However, the most homologous known germline Vh gene62 is only 75% homologous to CLL-249. Thus, while the CLL-249 h sequence is closely related to other published rearranged h genes, there is no published germline h sequence sufficiently homologous to CLL-249 to permit any evaluation of its deviation from germline. Figure 3 shows the heavy chain sequence of CLL-412. All three isolates are identical, except for nucleotide changes in isolate H2 in codon -11 and in H4 in codon +11. The V, gene sequence is identical (99% homologous) to that of 21/28, except for a single silent G to
CLL-412.
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- 19 -18 -17 -16 -15 -14 -13 -12 -11 -10 -9 -8 -1 -6 -5 -4 -3 -2 -1 _----c ----------__ ___ ---------------___ -__ --------------------------------- ---------------------------------------------------------- C difference in codon 2; 21/28 is a VH gene expressed in a hybridoma that secretes an IgM-K with anti-DNA and other autoreactivities derived from a patient with SLE.55 Because the 21/28 sequence has also been found identically in unrelated individuals:5 as well as now in CLL-412, it is very likely to be a germline sequence used in unmutated form in CLL-412. The single, silent base difference in codon 2 may be a polymorphism. As was found in CLL-249, the D segment of CLL-412 (Fig 4) is most homologous to the germline DN1 segment,56 and the CA to TG change seen in the DN1 segment in CLL-412 is translated in a different reading frame from DN1 in CLL-249. One nucleotide on the 5' end, and 11 on the 3' end of the D, are untemplated N sequences. The 54 joining segment is used without modification, as in cLL-249. Finally, although the CDNA synthesis and amplification were performed with a primer for the CY region, the portion of the constant region sequence 5 I of the primer is identical to the 5, portion of the first exon Of cy,63'64 and the Cr primer sequence fo11ows further 3' (bottom row, Fig 3) . This suggests that the amplification resulted from cross-hybridization of the Cy CH1 exon' where the cP and cy regions have sequence homology. The sequence, which is independent Of the primers, confirms the ELI% findings from heterohybridoma 412-2A11 that CLL-412 expresses an IgM, not IgG.
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The light chain of CLL-412 is shown in Fig 5. All three isolates were identical. The VK and JK gene sequences are 100% homologous to the corresponding segments of an expressed VK gene, 15AVK1, isolated in our laboratory from the circulating B-cell clone of a patient with autoimmune
DN1
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CLL-249 and previously described5' is present. However, hemolytic anemia mediated by a cold agglutinin. This identical VK sequence was also isolated from the granulocyte DNA of that patient and two other unrelated individua l~.~~ The joining segment of CLL-412 is identical to the published germline JK gene as we11.66 The only difference between CLL-412 and 15AVJ is an apparent 4-base insertion at the VK-J joint of CLL-412, which adds a proline residue as codon 95a.
Antigen Binding
Because the VH and Vt genes used in these two CLLs have been associated with autospecificity as discussed above, we assayed the heterohybridoma supematant antibodies for binding to several autoantigens. Supernatant from 412-21\11, and the affinity-purified human IgA-h from the supernatant of 249-1G11, were tested for binding activity against single-stranded DNA, double-stranded DNA, cardiolipin, and for rheumatoid factor activity. The supernatant from 412-2A11 demonstrated binding of singlestranded DNA and cardiolipin (Fig 6) , while the IgA-A from 249-1G11 demonstrated none of these activities. Neither antibody demonstrated activity against doublestranded DNA or rheumatoid factor (anti-IgG) activity. The autoantigen binding of the IgM,K from CLL-412 may reflect a molecular structure common to DNA and cardiol i~i n ,~' or may be part of a broader binding pattern like that described for polyreactive antib~dies.l'@,~~ and the supernatant from the CLL-412 heterohybridoma contained IgM, confirming the findings from the nucleotide sequences. Previous studies of isotype switching in CLL25,27 have not resolved the question of whether such variants exist because of limitations of the techniques used. The data presented here, at both the protein and the nucleic acid levels, clearly demonstrate that the CLL-249 clone was isotype-switched to IgA in vivo.
In contrast to CLL-249, CLL-412 expresses the IgM isotype, which is the typical finding in the majority of B-CLL. The initial indication that CLL-412 might secrete IgG illustrates the fact that studies of Ig expression in CLL using mitogen stimulation or heterohybridoma technology, as discussed below, can be misleading. It is necessary to prove that secreted antibody is derived from the CLL cell or its clonal progeny and not from B lymphocytes which are unrelated to the neoplastic clone.
Autoreactive Igs, such as the IgM-K of CLL-412, have previously been demonstrated in a fraction of CLLhybridomas," but the genetic basis for those specificities was not reported. Other laboratories have found a restricted set of autoantibody-associated V genes, expressed in unmutated, germline form, in several cases of CD5+ CLL.15J8,21J0 Such V genes have been shown to encode autoreactive and polyreactive antibodies in some monoclonal cell lines,55 although other CD5+ cell lines that use these genes did not show the expected autorea~tivity.~ Thus, the expression of such V genes in CLL may not necessarily result in the production of autoreactive Ig. However, in CLL-412, we have demonstrated directly that both heavy and light chain variable genes are unmutated germline genes and that they encode an Ig with autoreactivity. The combination of structural and functional Ig analysis The interpretation of the Ig structure-function analysis in CLL-249 is more speculative. CLL-249 appears to use the VH26 gene, although it may use a closely related VH gene; VH26, in germline sequence, is also expressed in the polyreactive autoantibody 18/2.55 Expression of VH26 or closely related genes has been previously described in CLL18 and in CD5+ cell lines,9 but, in these examples, the expressed VH gene contained nucleotide and predicted amino acid differences from the germline VH26 sequence, as CLL-249 does. It is possible that these differences explain why CLL-249 in this report and the CD5+ cell line A290 of Schutte et a19 lack anti-DNA and anticardiolipin activity, while 1812 has both autoreactivities. Alternatively, the light chain and CDR3 differences between 1812 and 249-1G11 could also contribute to differences in antigen binding. Mutagenesis studies would be necessary to prove that the heavy chain differences explain the change in antigen specificity.
The clinical behavior of the isotype-switched CLL-249 was unremarkable. The patient had an indolent course over 20 years, and at the time of death, the malignant clone continued to manifest the CLL phenotype, with no evidence of progression to a more differentiated B-cell phenotype as in Richter's syndrome or as has been described in individual cases of CLL associated with multiple myeloIt is possible that the isotype-switched CLL-249 resulted from transformation of an IgA-bearing CD5+ B cell, a phenotype shown to be the predominant subset of normal B-CLL.
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intestinal B cells.'3 Because isotype switching is thought to occur after B-cell activation, and typically in response to antigen or cytokines, CLL-249 may correspond to a more differentiated B cell than is usual in CLL.' Alternatively, an IgM-bearing CD5+ B cell may first have undergone malignant transformation followed by an uncommon isotypeswitching event. While the findings here do not discriminate between these alternatives, the example of CLL-249 provides additional evidence for genetic heterogeneity at the level of expressed immunoglobulin isotypes within the group of B-cell neoplasms classified as CLL.
